These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Biofilm formation in uropathogenic Escherichia coli: association with adhesion factor genes. Zamani H, Salehzadeh A. Turk J Med Sci; 2018 Feb 23; 48(1):162-167. PubMed ID: 29479978 [Abstract] [Full Text] [Related]
23. In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Ponnusamy P, Natarajan V, Sevanan M. Asian Pac J Trop Med; 2012 Mar 23; 5(3):210-3. PubMed ID: 22305786 [Abstract] [Full Text] [Related]
24. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon. Rafsanjany N, Senker J, Brandt S, Dobrindt U, Hensel A. J Agric Food Chem; 2015 Oct 14; 63(40):8804-18. PubMed ID: 26330108 [Abstract] [Full Text] [Related]
25. Global gene expression profiling and antibiotic susceptibility after repeated exposure to the carbon monoxide-releasing molecule-2 (CORM-2) in multidrug-resistant ESBL-producing uropathogenic Escherichia coli. Sahlberg Bang C, Demirel I, Kruse R, Persson K. PLoS One; 2017 Oct 14; 12(6):e0178541. PubMed ID: 28591134 [Abstract] [Full Text] [Related]
26. Increased biofilm formation in Escherichia coli isolated from acute prostatitis. Kanamaru S, Kurazono H, Terai A, Monden K, Kumon H, Mizunoe Y, Ogawa O, Yamamoto S. Int J Antimicrob Agents; 2006 Aug 14; 28 Suppl 1():S21-5. PubMed ID: 16828264 [Abstract] [Full Text] [Related]
27. Population structure, virulence potential and antibiotic susceptibility of uropathogenic Escherichia coli from Northwest England. Gibreel TM, Dodgson AR, Cheesbrough J, Fox AJ, Bolton FJ, Upton M. J Antimicrob Chemother; 2012 Feb 14; 67(2):346-56. PubMed ID: 22028202 [Abstract] [Full Text] [Related]
28. Relationship between phylogenetic groups, antibiotic resistance and patient characteristics in terms of adhesin genes in cystitis and pyelonephritis isolates of Escherichia coli. Er DK, Dundar D, Uzuner H, Osmani A. Microb Pathog; 2015 Dec 14; 89():188-94. PubMed ID: 26518125 [Abstract] [Full Text] [Related]
29. Fosfomycin tromethamine activity on biofilm and intracellular bacterial communities produced by uropathogenic Escherichia coli isolated from patients with urinary tract infection. González MJ, Da Cunda P, Notejane M, Zunino P, Scavone P, Robino L. Pathog Dis; 2019 Apr 01; 77(3):. PubMed ID: 31062019 [Abstract] [Full Text] [Related]
30. Biogenic amine tryptamine in human vaginal probiotic isolates mediates matrix inhibition and thwarts uropathogenic E. coli biofilm. Nair VG, Srinandan CS, Rajesh YBRD, Narbhavi D, Anupriya A, Prabhusaran N, Nagarajan S. Sci Rep; 2024 Jul 04; 14(1):15387. PubMed ID: 38965339 [Abstract] [Full Text] [Related]
31. Repurposing auranofin to combat uropathogenic Escherichia coli biofilms. Jang HI, Eom YB. J Appl Microbiol; 2019 Aug 04; 127(2):459-471. PubMed ID: 31087803 [Abstract] [Full Text] [Related]
32. Transposon mutagenesis identifies uropathogenic Escherichia coli biofilm factors. Hadjifrangiskou M, Gu AP, Pinkner JS, Kostakioti M, Zhang EW, Greene SE, Hultgren SJ. J Bacteriol; 2012 Nov 04; 194(22):6195-205. PubMed ID: 22984258 [Abstract] [Full Text] [Related]
33. Association of putative enteroaggregative Escherichia coli virulence genes and biofilm production in isolates from travelers to developing countries. Mohamed JA, Huang DB, Jiang ZD, DuPont HL, Nataro JP, Belkind-Gerson J, Okhuysen PC. J Clin Microbiol; 2007 Jan 04; 45(1):121-6. PubMed ID: 17093030 [Abstract] [Full Text] [Related]
34. UPEC strain characterization isolated from Mexican patients with recurrent urinary infections. Morales-Espinosa R, Hernandez-Castro R, Delgado G, Mendez JL, Navarro A, Manjarrez A, Cravioto A. J Infect Dev Ctries; 2016 Apr 28; 10(4):317-28. PubMed ID: 27130992 [Abstract] [Full Text] [Related]
35. Uropathogenic Escherichia coli isolates from pregnant women in different countries. Ramos NL, Sekikubo M, Dzung DT, Kosnopfel C, Kironde F, Mirembe F, Brauner A. J Clin Microbiol; 2012 Nov 28; 50(11):3569-74. PubMed ID: 22915606 [Abstract] [Full Text] [Related]
37. Synergistic mode of action of catechin, vanillic and protocatechuic acids to inhibit the adhesion of uropathogenic Escherichia coli on silicone surfaces. Bernal-Mercado AT, Gutierrez-Pacheco MM, Encinas-Basurto D, Mata-Haro V, Lopez-Zavala AA, Islas-Osuna MA, Gonzalez-Aguilar GA, Ayala-Zavala JF. J Appl Microbiol; 2020 Feb 28; 128(2):387-400. PubMed ID: 31573730 [Abstract] [Full Text] [Related]
38. Biofilm formation as a virulence determinant of uropathogenic Escherichia coli Dr+ strains. Zalewska-Piatek BM, Wilkanowicz SI, Piatek RJ, Kur JW. Pol J Microbiol; 2009 Feb 28; 58(3):223-9. PubMed ID: 19899615 [Abstract] [Full Text] [Related]
39. Anti-Biofilm Activity of Polyazolidinammonium Modified with Iodine Hydrate Ions against Microbial Biofilms of Uropathogenic Coliform Bacteria. Nechaeva OV, Tikhomirova EI, Zayarsky DA, Bespalova NV, Glinskaya EV, Shurshalova NF, Al Bayati BM, Babailova AI. Bull Exp Biol Med; 2017 Apr 28; 162(6):781-783. PubMed ID: 28432491 [Abstract] [Full Text] [Related]
40. Uropathogenic Escherichia coli forms biofilm aggregates under iron restriction that disperse upon the supply of iron. Rowe MC, Withers HL, Swift S. FEMS Microbiol Lett; 2010 Jun 28; 307(1):102-9. PubMed ID: 20402788 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]